Allison Elliott-Shannon

By

College: Medicine

Study Shows New Drug Compound Reduces Alzheimer's Pathology in Animal Model

Published: Jul 25, 2012

 

LEXINGTON, Ky. (July 25, 2012) — In a study published in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer’s pathology in a mouse model of the disease.

 

The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial cells. The drug can be taken by mouth and readily enters the brain. The new study tested the hypothesis that intervention with drugs like MW-151 could be effective as a preventive measure, when administered at an early stage before Alzheimer's pathology appears, as well as after disease symptoms have begun to appear.

 

"Early intervention with MW-151 in an Alzheimer's mouse model reduced the glial activation and proinflammatory cytokine overproduction, which resulted in improvement in neurologic outcomes," said Van Eldik. "The neurological outcomes included protection against the loss of critical nerve cell proteins and functional damage associated with learning and memory impairments."

 

In addition, the drug showed efficacy either before or after Alzheimer's disease was apparent, but was more effective when it was given before the disease was too far advanced, said Van Eldik. "The data support the hypothesis that selectively attenuating certain aspects of dysregulated brain inflammation is beneficial, especially when used early in the disease progression," she said.  "The outcomes suggest that therapeutic strategies targeting this pathological process have the potential to attenuate disease onset and progression."

In other words, administering the drug MW-151 early in the progression of Alzheimer's disease in an animal model resulted in improved outcomes, suggesting that administration of this drug before Alzheimer's symptoms are readily apparent may be a promising therapeutic strategy.  

 

Alzheimer’s disease is the sixth-leading cause of death in the United States, yet it is the only disease among the top 10 killers without a way to prevent, cure or slow its progression. The disease kills more people than diabetes, as well as more people than breast cancer and prostate cancer combined. The recent National Alzheimer’s Project Act clearly defines the rapidly growing nature of the problem and is the foundation for an evolving national plan to address this critical health and economic crisis.  Part of the national effort is to test explicit hypotheses about new disease modifying therapeutic strategies. 

 

Alzheimer's disease is a progressive disease that slowly destroys brain function, leading to memory impairments, difficulties with language and decision-making and eventually the inability to engage in normal activities of daily living and self care. The root causes of Alzheimer's are not understood. However, a rapidly growing body of experimental data and clinical observations on patients raise the possibility that unregulated brain inflammation, termed neuroinflammation, is a factor in susceptibility of disease onset and a contributor to disease progression. 

 

Regardless of neuroinflammation’s exact role, a prevailing hypothesis is that targeting of proinflammatory cytokine overproduction in the brain might be a useful therapeutic strategy to add to the armamentarium of emerging interventions. The primary brain cell target for such a disease modifying strategy would be glia, cells in the brain that produce proinflammatory cytokines and other innate immunity responses to injury or disease progression.  Glial cells normally cooperate with the nerve cells to keep the brain operating smoothly.  When an injury or change in the brain occurs, the glial cells mount a beneficial inflammation response to fight off the insult and restore the brain to its proper functioning. This beneficial process sometimes gets out of balance and the inflammation becomes too strong or does not shut off on schedule.

 

In AD, glial cells are over-activated and produce detrimental inflammatory molecules, which include the small proteins called proinflammatory cytokines, that contribute to nerve cell dysfunction or death. Drugs that selectively target cytokine up-regulation in glia are logical first attempts at this therapeutic strategy.

 

MEDIA CONTACT: Allison Elliott, allison.elliott@uky.edu

 

dsc_2763_vaneldiklabphoto2012.jpg
September
 
 
 
 
1
Louis Zoellar Bickett: Saving Myself
LGBTQ* and Friends Employee Picnic
Thu
2
Louis Zoellar Bickett: Saving Myself
Fri
3
Louis Zoellar Bickett: Saving Myself
Sat
4
Louis Zoellar Bickett: Saving Myself
Sun
5
Louis Zoellar Bickett: Saving Myself
Labor Day - Academic Holiday
Mon
6
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Wildcat Wellness Workshop: EXPRESSIONS
Tue
7
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Let's Talk!
Wildcat Wellness Workshop: MEDITATION
UK Women's Club Volleyball - Open Gym
From The Streets to The Stage With Monti Washington
Wed
8
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Wildcat Wellness Workshop: YOGA
#IAMACCEPTANCE Let's Talk Mental Health with Hakeem Rahim
Thu
9
Louis Zoellar Bickett: Saving Myself
Let's Talk!
2016 New Chinese Students Welcome Party
Accounting Internship & Career Fair
Question, Persuade, Refer (QPR) Suicide Prevention Training
Fri
10
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Sat
11
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Whipping In The Kitchen
Sun
12
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Let's Talk!
Mon
13
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Wildcat Wellness Workshop: EXPRESSIONS
UKWC Welcome Coffee
Tue
14
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Last Day to Drop a Course Without Appearing on Transcript
Let's Talk!
Wildcat Wellness Workshop: MEDITATION
Greek Park Pictures
Wed
15
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Let's Talk!
Let's Talk!
Wildcat Wellness Workshop: YOGA
Thu
16
Louis Zoellar Bickett: Saving Myself
Let's Talk!
A Day of Rising Strong
Fri
17
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Sat
18
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Sun
19
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Let's Talk!
Mon
20
Louis Zoellar Bickett: Saving Myself
Let's Talk!
UK Women's Forum Board Meeting
UK Elder Care Lunch & Learn - Best Friends Approach to Dementia Care
Wildcat Wellness Workshop: EXPRESSIONS
Cuban Heritage Festival
Tue
21
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Last Day to Withdraw to Receive 50% Refund
Let's Talk!
Wildcat Wellness Workshop: MEDITATION
Horticulture Club Farm Market Sale
Wed
22
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Let's Talk!
Let's Talk!
Wildcat Wellness Workshop: YOGA
TGIT with SAB
Thu
23
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Fri
24
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Sat
25
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Film Screening of "The Fly Room"
Sun
26
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Film Screening of "The Fly Room"
Let's Talk!
Empower: People of Color Support Group
Film Screening of "The Fly Room"
Mon
27
Louis Zoellar Bickett: Saving Myself
Let's Talk!
FIFA Tournament
Wildcat Wellness Workshop: EXPRESSIONS
UK Engineering and Computer Science Career Fair
Banned Books--A short history
Tue
28
Louis Zoellar Bickett: Saving Myself
Let's Talk!
FIFA Tournament
Let's Talk!
Wildcat Wellness Workshop: MEDITATION
Horticulture Club Farm Market Sale
Cats Got The Vote
Business Internship & Career Fair
Women In Technology Gala event for UK undergraduate women
Wed
29
Louis Zoellar Bickett: Saving Myself
Let's Talk!
FIFA Tournament
Let's Talk!
Let's Talk!
Wildcat Wellness Workshop: YOGA
Yoga at Commonwealth Stadium
Thu
30
Louis Zoellar Bickett: Saving Myself
Let's Talk!
Indonesia Focus Conference
Indonesia Focus Conference
Craft Writing: Beer, the Digital, and Craft Culture
Fri
 
Sep 26
Let's Talk! 09/26/2016

Repeats every week until Mon Dec 05 2016 .
Mon, 09/26/2016

Mon, 09/26/2016

Repeats every 7 days until Tue Dec 13 2016 .
Tue, 09/27/2016

Tue, 09/27/2016 - Thu, 09/29/2016

Tue, 09/27/2016

Reset Page